Why the communicable/non-communicable disease dichotomy is problematic for public health control strategies: implications of multimorbidity for health systems in an …

T Oni, N Unwin - International health, 2015 - academic.oup.com
In today's globalized world, rapid urbanization, mechanization of the rural economy, and the
activities of trans-national food, drink and tobacco corporations are associated with …

Human immunodeficiency virus in an aging population, a complication of success

JB Kirk, MB Goetz - Journal of the American Geriatrics Society, 2009 - Wiley Online Library
The proportion of human immunodeficiency virus (HIV)‐infected patients aged 50 and older
has greatly increased since the beginning of the epidemic, particularly since 1996, when …

HIV-positive–to–HIV-positive kidney transplantation—results at 3 to 5 years

E Muller, Z Barday, M Mendelson… - New England Journal of …, 2015 - Mass Medical Soc
Background The outcome of kidney transplantation in human immunodeficiency virus (HIV)–
positive patients who receive organs from HIV-negative donors has been reported to be …

Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons

AI Choi, E Vittinghoff, SG Deeks, CC Weekley, Y Li… - Aids, 2011 - journals.lww.com
Objective: Abacavir use has been associated with cardiovascular risk, but it is unknown
whether this association may be partly explained by patients with kidney disease being …

[PDF][PDF] Morbidity in older HIV-infected patients: impact of long-term antiretroviral use

G Guaraldi, M Prakash, C Moecklinghoff, HJ Stellbrink - Aids Rev, 2014 - researchgate.net
The introduction of HAART has represented a major advance in the care of people with HIV.
By markedly increasing life expectancy, HAART has significantly changed the pattern of HIV …

Similar risk of renal events among patients treated with tenofovir or entecavir for chronic hepatitis B

RG Gish, MD Clark, SD Kane, RE Shaw… - Clinical …, 2012 - Elsevier
BACKGROUND & AIMS: Tenofovir is a nucleotide reverse-transcriptase inhibitor approved
for treatment of human immunodeficiency virus infection, as well as chronic hepatitis B …

Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients

L Peters, D Grint, JD Lundgren, JK Rockstroh… - Aids, 2012 - journals.lww.com
Background: Several studies have reported on an association between hepatitis C virus
(HCV) antibody status and the development of chronic kidney disease (CKD), but the role of …

Role of traditional risk factors and antiretroviral drugs in the incidence of chronic kidney disease, ANRS CO3 Aquitaine cohort, France, 2004–2012

P Morlat, A Vivot, MA Vandenhende, FA Dauchy… - PLoS …, 2013 - journals.plos.org
Objective To examine the role of antiretroviral drugs (ART), HIV-related and traditional risk
factors on the incidence of chronic kidney disease (CKD) in HIV-infected patients. Design …

Efficacy and safety of entecavir versus tenofovir treatment in chronic hepatitis B patients: a randomized controlled trial

T Sriprayoon, C Mahidol, T Ungtrakul… - Hepatology …, 2017 - Wiley Online Library
Aim Entecavir (ETV) and tenofovir disoproxil fumarate (TDF) are considered among the most
potent antiviral agents for the treatment of chronic hepatitis B infection. We aimed to …

Prevalence of chronic kidney disease among people living with HIV/AIDS in Burundi: a cross-sectional study

J Cailhol, B Nkurunziza, H Izzedine, E Nindagiye… - BMC nephrology, 2011 - Springer
Background Since little is known about chronic kidney disease (CKD) among people living
with HIV/AIDS (PLWHA) in Sub-Saharan Africa, the prevalence and nature of CKD were …